Fei Xiong

Years Active: 2021-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Zhang, Yuan Zou, Longmin Chen, Fei Sun, Qianqian Xu, Qing Zhou, Yi Wang, Xi Luo, Na Wang, Yang Li, Shu Zhang, Fei Xiong, Ping Yang, Shiwei Liu, Yang Tao, Jian-Ping Weng, Décio L Eizirik, Jianping Weng, Zhiguang Zhou, Cong-Yi Wang
Myo9b mutations are associated with altered dendritic cell functions and increased susceptibility to autoimmune diabetes onset. Nature communications 14 (1) (2023)
Fei Sun, Fa-Xi Wang, He Zhu, Tian-Tian Yue, Chun-Liang Yang, Jia-Hui Luo, Xi Luo, Hai-Feng Zhou, Shan-Jie Rong, Wan-Ying Lu, Qing Zhou, Ping Yang, Fei Xiong, Yan-Jun Liu, Tong Yan, Yun-Fei Liao, Shu Zhang, Cong-Yi Wang
SUMOylation of PDPK1 Is required to maintain glycolysis-dependent CD4 T-cell homeostasis. Cell death & disease 13 (2) (2022)
Teng Huang, Jia Song, Jia Gao, Jia Cheng, Hao Xie, Lu Zhang, Yu-Han Wang, Zhichao Gao, Yi Wang, Xiaohui Wang, Jinhan He, Shiwei Liu, Qilin Yu, Shu Zhang, Fei Xiong, Qing Zhou, Cong-Yi Wang
Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling. Nature communications 13 (1) (2022)
Tian-Tian Yue, Fei Sun, Faxi Wang, Chunliang Yang, Jiahui Luo, Shanjie Rong, Haifeng Zhou, Jun Xiao, Xiaohui Wang, Qing Zhou, Ping Yang, Shu Zhang, Wen Li, Fei Xiong, Qilin Yu, Cong-Yi Wang
MBD2 acts as a repressor to maintain the homeostasis of the Th1 program in type 1 diabetes by regulating the STAT1-IFN-γ axis. Cell death and differentiation (2021)

Fei Xiong.css-eqlu8i{font-size:small;padding-left:4px;}